Managing Myeloma
- 2010-10-10 - ESMO 35: High response rates seen in Phase-III trial of chemotherapy, new drug and stem cells in myeloma
- 2010-10-10 - Oncologist Bikes 235 Miles To Fight Blood Cancer
- 2010-10-08 - ESMO: Surgical technique relieves painful spine fractures in patients with metastatic cancer
- 2010-10-08 - Onyx Delay Carfilzomib Approval
- 2010-10-07 - A sick CEO's full disclosure- Hugh Martin, Pacific Biosiences Fights on to Make Gene Sequencing Available to Everyone- CNNMONEY.com
- 2010-10-07 - Precious Cat Inc., Multiple Myeloma Research Foundation (MMRF) Join Forces to Accelerate Development of New Cancer Treatments
- 2010-10-07 - Carfilzomib Application For FDA Approval Is Delayed- The Myeloma Beacon
- 2010-10-05 - Chinese Study Suggests That Bortezomib May Protect Against Blood Clots In Newly Diagnosed Multiple Myeloma Patients-The Myeloma Beacon
- 2010-10-05 - NEWS FLASH: Institute for Myeloma and Bone Cancer Research in Los Angeles Proudly Announces Roger Townsend to join its Board of Directors as Treasurer.
- 2010-09-30 - NEWS FLASH: TGen-Mayo Clinic study discovers role of DNA methylation in multiple myeloma blood cancer: Report finds development of multiple myeloma is tied to 'hypomethylation'
- 2010-09-28 - Once-Weekly Bortezomib Is Equally Effective But Better Tolerated In Elderly Multiple Myeloma Patients
- 2010-09-27 - U.K. News Story: Charity claims cancer patients are being denied NHS-funded drug
- 2010-09-27 - Spokane firefighter back home after life-saving treatment
- 2010-09-24 - See What Your Patient's are Reading: Multiple Myeloma Advocacy Sheet-Empowher
- 2010-09-23 - For Multiple Myeloma Treatment, More Surveyed European Clinicians Consider the Combination of Immunomodulatory Agents and Proteasome Inhibitors Promising With Respect to Efficacy Than Any Other Drug Regimen Combinations